NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 1 percent decline in its second quarter revenues but still beat analysts' average estimate. 

For the three months ended June 27, the firm posted $4.27 billion in revenues, down from $4.32 billion from the year-ago quarter but above the consensus Wall Street estimate of $4.17 billion.

Thermo Fisher said that its organic revenue growth was 6 percent. The firm said that divestitures, net of acquisitions, decreased its revenue by 1 percent in the quarter and currency translation reduced revenue by 6 percent. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.